REPL · NASDAQ
Replimune Group (REPL) Stock Price & Fundamentals
Replimune Group (REPL) closed at $887.25 on Oct 9, 2026, down 1.18% from the previous close of $897.84.
Share price, past year
1Y −4.41%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $887.25 |
| Sep 30, 2026 | $883.28 |
| Aug 31, 2026 | $910.84 |
| Jul 31, 2026 | $880.22 |
| Jun 30, 2026 | $940.37 |
| May 29, 2026 | $966.77 |
| Apr 30, 2026 | $961.41 |
| Mar 31, 2026 | $917.99 |
| Feb 27, 2026 | $962.71 |
| Jan 30, 2026 | $995.08 |
| Dec 31, 2025 | $986.09 |
| Nov 28, 2025 | $957.61 |
| Oct 31, 2025 | $948.32 |
Key statistics
- Market cap
- $74.51B
- P/E (TTM)
- —
- EPS (TTM)
- −$3.15
- Revenue (TTM)
- —
- Net income (TTM)
- −$297.01M
- Shares outstanding
- 84M
- Dividend yield
- —
- 52-week range
- $857.32 – $1,007.84
Replimune Group's market cap is $74.51B, based on a share price of $887.25 and 84M shares outstanding as of Jun 30, 2026.
Financials
Replimune Group reported a net loss of $313.94M in fiscal 2026.
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2019ended Jun 30, 2018 | $0.00 | — | — |
Company profile
- Name
- Replimune Group, Inc.
- Ticker
- REPL
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 500 Unicorn Park, Woburn, MA 01801
- Incorporated in
- DE
- Fiscal year ends
- March
- SEC CIK
- 0001737953
Recent SEC filings
- Sep 16, 2026
- Aug 14, 2026
- Aug 14, 2026
- Aug 10, 2026
- Aug 7, 2026
- Jul 31, 2026
- Jul 30, 2026
- Jun 29, 2026
Frequently asked questions
What is Replimune Group's stock price?
Replimune Group (REPL) closed at $887.25 on Oct 9, 2026, down 1.18% from the previous close of $897.84.
What is Replimune Group's market cap?
Replimune Group's market cap is $74.51B, based on a share price of $887.25 and 84M shares outstanding as of Jun 30, 2026.
Does Replimune Group pay a dividend?
Replimune Group's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Replimune Group, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures